当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 利润表

金城医药

(300233)

  

流通市值:62.19亿  总市值:64.22亿
流通股本:3.72亿   总股本:3.84亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入1,360,240,655.35721,919,205.163,373,387,400.672,515,318,391.16
  营业收入1,360,240,655.35721,919,205.163,373,387,400.672,515,318,391.16
二、营业总成本1,309,982,354.22682,091,200.853,103,164,108.882,333,206,417.21
  营业成本868,771,753.18475,205,404.722,019,599,405.011,505,877,666.08
  税金及附加17,975,972.199,250,592.8339,270,519.8429,272,625.07
  销售费用160,343,056.8674,794,902.94496,387,128.75389,547,908.92
  管理费用187,935,873.2390,172,148.26378,462,118.25284,393,309.03
  研发费用73,906,078.9332,823,976.17170,343,707.78122,556,886.36
  财务费用1,049,619.83-155,824.07-898,770.751,558,021.75
  其中:利息费用6,055,193.53,364,620.1918,478,065.5914,547,591.78
  其中:利息收入3,927,714.062,394,201.0712,898,144.2310,449,035.67
三、其他经营收益
  加:公允价值变动收益-143,866.15-714.8386,537.6-305,092.09
  加:投资收益967,435.41817,894.85-1,665,130.72-1,524,342.93
  资产处置收益-388,847.35-396,165.761,454,864.31,560,628.81
  资产减值损失(新)-8,134,729.93-2,760,402.18-32,634,926.91-10,161,619.9
  信用减值损失(新)8,574,187.257,015,544.061,397,494.564,462,563.61
  其他收益10,984,825.315,588,626.3228,276,042.2619,122,240.82
四、营业利润62,117,305.6750,092,786.77267,138,172.88195,266,352.27
  加:营业外收入139,296.638,759.753,846,482.492,175,423.89
  减:营业外支出2,471,622.62331,563.682,536,632.21500,156.65
五、利润总额59,784,979.6549,799,982.84268,448,023.16196,941,619.51
  减:所得税费用14,818,901.913,501,079.1860,712,679.0334,840,797.3
六、净利润44,966,077.7536,298,903.66207,735,344.13162,100,822.21
(一)按经营持续性分类
  持续经营净利润44,966,077.7536,298,903.66207,735,344.13162,100,822.21
(二)按所有权归属分类
  归属于母公司股东的净利润43,383,223.5635,054,760.33196,780,752.11151,053,816.96
  少数股东损益1,582,854.191,244,143.3310,954,592.0211,047,005.25
  扣除非经常损益后的净利润38,730,480.0632,952,569.73179,904,473.7138,362,981.4
七、每股收益
  (一)基本每股收益0.110.090.520.4
  (二)稀释每股收益0.110.090.520.4
八、其他综合收益-2,100,000-23,268,580.25-
  归属于母公司股东的其他综合收益-2,100,000-23,268,580.25-
九、综合收益总额42,866,077.7536,298,903.66231,003,924.38162,100,822.21
  归属于母公司股东的综合收益总额41,283,223.5635,054,760.33220,049,332.36151,053,816.96
  归属于少数股东的综合收益总额1,582,854.191,244,143.3310,954,592.0211,047,005.25
公告日期2025-08-212025-04-292025-03-282024-10-25
审计意见(境内)标准无保留意见
TOP↑